Emergent Biosolutions restarts manufacturing at Canton facility

Emergent Biosolutions restarts manufacturing at Canton facility
Emergent restarts Canton manufacturing

Emergent Biosolutions has restarted manufacturing operations at its Canton facility. The company marked the occasion with a celebration attended by President and CEO Joseph Papa and Secretary Eric Paley.

Joseph Papa expressed optimism about the achievements and future prospects of the Emergent Biosolutions team as they resume activity at the Canton site.

Earlier this year, Emergent Biosolutions outlined its strategy for tackling biological threats through both stockpiling and surge manufacturing in a public statement. The company has also expanded its commercial reach after winning a Canadian government contract to supply NARCAN Nasal Spray in a competitive bidding process. These developments follow ongoing efforts at Emergent to strengthen its manufacturing operations.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.